A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. (Q50939645)
Jump to navigation
Jump to search
scientific article published on 5 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. |
scientific article published on 5 September 2012 |
Statements
1 reference
A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. (English)
1 reference
Kenneth A Lichtenstein
1 reference
Carl Armon
1 reference
Vijaya Nagabhushanam
1 reference
Benjamin J Efaw
1 reference
Ashley Frazer-Abel
1 reference
Melissa E Hiserote
1 reference
Rafeul Alam
1 reference
5 September 2012
1 reference
1 reference
17
1 reference
7
1 reference
1301-1309
1 reference
Identifiers
1 reference
1 reference